This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Elizabeth Henderson, PhD
Scientist II at Xencor
Speaker

Profile

Elizabeth completed her BSc at the University of Utah in 2010, followed by a Master of Business and Science (MBS) in 2014 and a PhD in 2019 from the Keck Graduate Institute. She further honed her expertise through postdoctoral research at City of Hope and joined Xencor in 2021. Her current work centers on pioneering in vivo antibody discovery methods, contributing to the advancement of Xencor’s diverse pipeline of antibody-based therapeutics.

Agenda Sessions

  • Early Career Scientist Presentation #2: Development of MICA/B Antibodies for Cancer Treatment

    10:25am